Loading companies…
AB
Axio BioPharma
United States · Enterprise software · Biotech
A data platform that connects pharmaceutical manufacturers and their production partners while each organization keeps control of its own systems and records.
Sharing manufacturing context without centralizing raw data
Axio Lattice is designed for pharmaceutical sponsors and manufacturing partners that need to coordinate process information during technology transfers and production work. Its connectors read records from each organization’s existing systems, while local Nodes keep raw data within the chosen company boundary.
Rosetta maps different field names, units and process terminology to shared concepts so both sides can review an approved view of the same manufacturing information. Axio says Lattice is still in development; its first deployments and continued work on the Rosetta mapping layer are planned.
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Pre-seed | $2.4M | Chemical Angel Network — Role not disclosedChisos Capital — Role not disclosedElmstead Partners — Role not disclosed |
Investors
Chemical Angel NetworkPre-seedChisos CapitalPre-seedElmstead PartnersPre-seedCoverage
Sep 21, 2026Axio BioPharma · Pre-seedSimilar companies
AAligatorAI media intelligence for PR and marketing teams to monitor brand coverage, understand audience and competitor sentiment, and spot reputational risks across channels and languages.$1.2M · Seed
AnaCardioAnaCardio is a clinical-stage biopharmaceutical company developing medicines intended to improve heart muscle function in people with heart failure.€62.5M · Series B
AventixAventix builds sensor-based analytical instruments for laboratories. Its first product, Scarlett 01, measures liquid volumes across microplate wells without touching the sample, helping R&D teams check dispensing quality and catch volume variation before it affects assay results.€1.2M · Pre-seed